Galera Therapeutics Stock Surges After Its Lead Candidate Shows Median OS Of 20 Months In Pancreatic Cancer Study
Robert Beardsley - Co-Founder, Executive Chair & Chief Operating Officer - Galera Therapeutics, Inc. | LinkedIn
Robert Beardsley - Co-Founder, Executive Chair & Chief Operating Officer - Galera Therapeutics, Inc. | LinkedIn
![Galera Therapeutics Inc.: Submission of Matters to a Vote of Security Holders (Form 8-K) - MoneyController (ID 127704) Galera Therapeutics Inc.: Submission of Matters to a Vote of Security Holders (Form 8-K) - MoneyController (ID 127704)](https://www.moneycontroller.co.uk/upload/aziende/galera-therapeutics-inc_20210708072039.jpg)